MITCHELL DEAN J — SEC Form 4 filings
SEC reporting owner CIK 1199297. 11 Form 4 filings on record with FilingPulse; latest filed 2026-06-16.
Transaction summary — filings shown
Covers all 11 filings on record, filed 2024-02-12 to 2026-06-16. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): none reported.
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 34.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Praxis Precision Medicines, Inc. (PRAX) | Director | 4 | — | — | 10 |
| ImmunoGen, Inc. (IMGN) | Director | 1 | — | — | 9 |
| Theravance Biopharma, Inc. (TBPH) | Director | 3 | — | — | 6 |
| PRECIGEN, INC. (PGEN) | Director | 2 | — | — | 5 |
| Kinnate Biopharma Inc. (KNTE) | Director | 1 | — | — | 4 |
Form 4 filings — MITCHELL DEAN J
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-06-16 | 4 | Theravance Biopharma, Inc. (TBPH) | Grant/award (A): 6,009 @ $0 · Grant/award (A): 13,398 (derivative) @ $0 | EDGAR |
| 2026-06-12 | 4 | Praxis Precision Medicines, Inc. (PRAX) | Grant/award (A): 1,371 @ $0 · Grant/award (A): 648 (derivative) @ $0 | EDGAR |
| 2025-09-25 | 4 | Praxis Precision Medicines, Inc. (PRAX) | Option exercise (M): 1,932 @ $14.36 · Option exercise (M): 8,566 @ $44.25 · Option exercise (M): 1,753 @ $44.04 · Option exercise (M): 1,932 (derivative) @ $0 · Option exercise (M): 8,566 (derivative) @ $0 · Option exercise (M): 1,753 (derivative) @ $0 | EDGAR |
| 2025-06-27 | 4 | Praxis Precision Medicines, Inc. (PRAX) | Grant/award (A): 10,520 (derivative) @ $0 | EDGAR |
| 2025-05-21 | 4 | Theravance Biopharma, Inc. (TBPH) | Grant/award (A): 10,649 @ $0 · Grant/award (A): 24,258 (derivative) @ $0 | EDGAR |
| 2024-06-06 | 4 | Praxis Precision Medicines, Inc. (PRAX) | Grant/award (A): 8,566 (derivative) @ $0 | EDGAR |
| 2024-05-10 | 4 | Theravance Biopharma, Inc. (TBPH) | Grant/award (A): 10,537 @ $0 · Grant/award (A): 23,576 (derivative) @ $0 | EDGAR |
| 2024-04-05 | 4 | Kinnate Biopharma Inc. (KNTE) | Disposition to issuer (D): 121,503 (derivative) · Disposition to issuer (D): 20,250 (derivative) · Disposition to issuer (D): 20,250 (derivative) · Disposition to issuer (D): 25,000 (derivative) | EDGAR |
| 2024-03-18 | 4 | PRECIGEN, INC. (PGEN) | Grant/award (A): 39,510 @ $1.43 · Grant/award (A): 87,412 (derivative) @ $0 · Grant/award (A): 101,626 (derivative) @ $0 | EDGAR |
| 2024-03-12 | 4 | PRECIGEN, INC. (PGEN) | Option exercise (M): 106,837 · Option exercise (M): 106,837 (derivative) @ $0 | EDGAR |
| 2024-02-12 | 4 | ImmunoGen, Inc. (IMGN) | Disposition to issuer (D): 103,000 · Disposition to issuer (D): 13,090 (derivative) · Disposition to issuer (D): 142,667 (derivative) · Disposition to issuer (D): 10,000 (derivative) · Disposition to issuer (D): 10,000 (derivative) · Disposition to issuer (D): 18,000 (derivative) · +3 more | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1199297 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →